Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Psychiatrische Praxis|January 17, 2004
[Notes concerning the uncritical handling of the diagnosis "Kleptomania"]Elmar Habermeyer, Karsten Heekeren
Psychopathology|August 18, 2011
The negative symptoms of schizophrenia: category or continuum?Stefan Kaiser, Karsten Heekeren, Joe J Simon
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 15, 2005
Deficient inhibition of return in schizophrenia-further evidence from an independent sampleEuphrosyne Gouzoulis-Mayfrank, Susanne Arnold, Karsten Heekeren
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 6, 2018
Inhibition of return (IOR) in patients with schizophrenia and cannabis useThomas Schnell, Karsten Heekeren, Jörg Daumann, et al.
Psychopharmacology|January 15, 2004
Plasticity of the acoustic startle reflex in currently abstinent ecstasy (MDMA) usersKarsten Heekeren, Jörg Daumann, Mark A Geyer, et al.
Neuropsychobiology|February 26, 2004
Attentional modulation of prepulse inhibition: a new startle paradigmKarsten Heekeren, Ulrich Meincke, Mark A Geyer, et al.
Biological Psychiatry|September 1, 2004
Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging studyJörg Daumann, Thomas Fischermann, Karsten Heekeren, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2004
Blunted inhibition of return in schizophrenia-evidence from a longitudinal studyEuphrosyne Gouzoulis-Mayfrank, Karsten Heekeren, Tatjana Voss, et al.
Schizophrenia Research|February 1, 2017
Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-convertersMichael P Hengartner, Karsten Heekeren, Diane Dvorsky, et al.
Psychopharmacology|September 17, 2004
Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) usersJörg Daumann, Thomas Fischermann, Karsten Heekeren, et al.
Pageof 6